|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.42 CNY | +1.91% |
|
+2.51% | +3.22% |
| 17/11 | Yifeng Pharmacy Chain Vice Presidents Reduce Stakes | MT |
| 29/25/29 | Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Capitalization | 2.72TCr 389.64Cr 334.82Cr 312.23Cr 290.13Cr 541.34Cr 35TCr 583.72Cr 3.59TCr 1.41TCr 17TCr 1.46TCr 1.43TCr 62TCr | P/E ratio 2025 * |
16x | P/E ratio 2026 * | 13.4x |
|---|---|---|---|---|---|
| Enterprise value | 2.51TCr 359.7Cr 309.09Cr 288.24Cr 267.84Cr 499.74Cr 32TCr 538.87Cr 3.31TCr 1.3TCr 16TCr 1.35TCr 1.32TCr 57TCr | EV / Sales 2025 * |
1.02x | EV / Sales 2026 * | 0.89x |
| Free-Float |
45.78% | Yield 2025 * |
2.64% | Yield 2026 * | 2.94% |
| 1 day | +1.91% | ||
| 1 week | +2.51% | ||
| Current month | +3.22% | ||
| 1 month | +0.45% | ||
| 3 months | -8.53% | ||
| 6 months | -8.34% | ||
| Current year | +3.22% |
| 1 week | 21.89 |  | 22.87 |
| 1 month | 20.81 | | 22.87 |
| Current year | 21.61 | | 22.87 |
| 1 year | 20.81 | | 29.26 |
| 3 years | 17.56 | | 39.07 |
| 5 years | 17.56 | | 49.5 |
| 10 years | 7.9 | | 50.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Gao
CEO | Chief Executive Officer | 57 | 01/06/2008 |
Yong Hui Wang
DFI | Director of Finance/CFO | 51 | 25/06/2024 |
You Cheng Gao
PRN | Corporate Officer/Principal | 57 | 01/06/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
Yi Gao
CHM | Chairman | 57 | 01/06/2008 |
Feng Gao
BRD | Director/Board Member | 54 | 01/06/2008 |
You Cheng Gao
BRD | Director/Board Member | 57 | 01/06/2008 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.91% | +2.51% | -8.53% | -38.60% | 382.51Cr | |
| +0.52% | +15.81% | +150.09% | +0.82% | 2.76TCr | |
| +2.83% | +22.93% | +106.96% | -10.66% | 1.32TCr | |
| -1.28% | -3.48% | +17.18% | +23.56% | 667.89Cr | |
| -0.25% | +5.03% | -7.11% | +24.01% | 497.98Cr | |
| -0.21% | +1.57% | -20.95% | -47.33% | 325.68Cr | |
| -0.05% | +4.34% | +34.18% | -48.22% | 302.8Cr | |
| -2.78% | -4.44% | -11.69% | +60.58% | 283.32Cr | |
| -0.79% | +0.26% | +56.30% | - | 199.52Cr | |
| -0.14% | +2.40% | -0.71% | +22.27% | 189.73Cr | |
| Average | -0.02% | +3.95% | +31.57% | -1.51% | 692.8Cr | |
| Weighted average by Cap. | +0.56% | +9.95% | +82.46% | -1.11% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.47TCr 354.05Cr 304.23Cr 283.7Cr 263.62Cr 491.88Cr 32TCr 530.39Cr 3.26TCr 1.28TCr 15TCr 1.33TCr 1.3TCr 56TCr | 2.69TCr 385.45Cr 331.22Cr 308.87Cr 287.01Cr 535.51Cr 35TCr 577.44Cr 3.55TCr 1.4TCr 17TCr 1.45TCr 1.42TCr 61TCr |
| Net income | 169.63Cr 24Cr 21Cr 19Cr 18Cr 34Cr 2.2TCr 36Cr 224Cr 88Cr 1.05TCr 91Cr 89Cr 3.87TCr | 196.19Cr 28Cr 24Cr 23Cr 21Cr 39Cr 2.54TCr 42Cr 259.08Cr 101.8Cr 1.21TCr 105.47Cr 103.31Cr 4.48TCr |
| Net Debt | -208.85Cr -30Cr -26Cr -24Cr -22Cr -42Cr -2.7TCr -45Cr -275.8Cr -108.37Cr -1.29TCr -112.28Cr -109.97Cr -4.77TCr | -312.48Cr -45Cr -38Cr -36Cr -33Cr -62Cr -4.05TCr -67Cr -412.64Cr -162.14Cr -1.93TCr -167.98Cr -164.54Cr -7.13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 22.42 ¥ | +1.91% | 1,57,74,000 |
| 12/26/12 | 22.00 ¥ | -0.95% | 1,06,88,690 |
| 09/26/09 | 22.21 ¥ | +0.59% | 82,84,452 |
| 08/26/08 | 22.08 ¥ | -0.45% | 61,44,057 |
| 07/26/07 | 22.18 ¥ | +0.27% | 1,06,16,830 |
End-of-day quote Shanghai S.E., January 13, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603939 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition